accountOct 21 (Reuters) - King Pharmaceuticals Inc (KG.N) said U.S. health regulators declined to approve its heart imaging agent, CorVue injection. Earlier this year, an advisory panel to the U.S. Food and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-FDA declines to approve King's heart imaging drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
